Accessibility Tools
Invert colors
Monochrome
Dark contrast
Light contrast
Low saturation
High saturation
Highlight links
Highlight headings
Screen reader
Read mode
Content scaling
100
%
Font size
100
%
Line height
100
%
Letter spacing
100
%
(678) 384-7220
info@geovax.com
About Us
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Clinical Trials
Investors
Corporate Profile
Press Releases
Media
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Careers
Contact
SEC Filings
SEC Filings
Group by
None
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
Search:
Clear filters
Year
All
2018
2019
2020
2021
2022
2023
2024
Description
All
8-K
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Annual Report
Current Report
General Statement of Acquisition of Beneficial Ownership
Initial Ownership Report
Notice of Effectiveness
Other Definitive Proxy Statement
Other Definitive Proxy Statements
Other Preliminary Proxy Statement
Other Preliminary Proxy Statements
Post-Effective amendments for registration status
Preliminary Proxy Soliciting Materials
Prospectus
Prospectus Supplement
Quarterly Report
Registration Statement
Statement of Changes in Beneficial Ownership
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
Annual Report
(12)
No records
2024
03-11
Annual Report
10-K/A
View
2024
02-29
Annual Report
10-K
View
2023
04-27
Annual Report
10-K/A
View
2023
03-23
Annual Report
10-K
View
2022
03-09
Annual Report
10-K
View
2021
04-28
Annual Report
10-K/A
View
2021
03-23
Annual Report
10-K
View
2020
04-28
Annual Report
10-K/A
View
2020
03-24
Annual Report
10-K
View
2019
04-12
Annual Report
10-K/A
View
2019
03-26
Annual Report
10-K
View
2018
03-23
Annual Report
10-K
View
Current Report
(75)
No records
2024
03-01
Current Report
8-K
View
2024
02-16
Current Report
8-K
View
2024
01-31
Current Report
8-K
View
2024
01-16
Current Report
8-K
View
2023
12-08
Current Report
8-K
View
2023
12-04
Current Report
8-K
View
2023
11-09
Current Report
8-K
View
2023
08-10
Current Report
8-K
View
2023
08-02
Current Report
8-K
View
2023
07-18
Current Report
8-K
View
2023
06-12
Current Report
8-K
View
2023
05-05
Current Report
8-K
View
2023
03-24
Current Report
8-K
View
2022
12-09
Current Report
8-K
View
2022
12-08
Current Report
8-K
View
2022
11-14
Current Report
8-K
View
2022
01-20
Current Report
8-K
View
2022
01-04
Current Report
8-K
View
2022
09-01
Current Report
8-K
View
2022
09-01
Current Report
8-K
View
2022
08-04
Current Report
8-K
View
2022
05-27
Current Report
8-K
View
2022
05-02
Current Report
8-K
View
2022
04-27
Current Report
10-K/A
View
2022
03-10
Current Report
8-K
View
2021
12-15
Current Report
8-K
View
2021
11-12
Current Report
8-K
View
2021
11-10
Current Report
8-K
View
2021
09-30
Current Report
8-K
View
2021
09-29
Current Report
8-K
View
2021
08-20
Current Report
8-K
View
2021
08-11
Current Report
8-K
View
2021
05-07
Current Report
8-K
View
2021
03-23
Current Report
8-K
View
2021
02-11
Current Report
8-K
View
2021
02-11
Current Report
8-K
View
2020
11-30
Current Report
8-K
View
2020
11-05
Current Report
8-K
View
2020
10-26
Current Report
8-K
View
2020
09-29
Current Report
8-K
View
2020
09-25
Current Report
8-K
View
2020
08-10
Current Report
8-K
View
2020
08-10
Current Report
8-K
View
2020
06-26
Current Report
8-K
View
2020
06-25
Current Report
8-K
View
2020
05-22
Current Report
8-K
View
2020
05-06
Current Report
8-K
View
2020
04-20
Current Report
8-K
View
2020
03-25
Current Report
8-K
View
2020
03-09
Current Report
8-K
View
2020
01-24
Current Report
8-K
View
2020
01-23
Current Report
8-K
View
2020
01-03
Current Report
8-K
View
2019
11-14
Current Report
8-K
View
2019
11-07
Current Report
8-K
View
2019
11-01
Current Report
8-K
View
2019
10-18
Current Report
8-K
View
2019
10-07
Current Report
8-K
View
2019
10-01
Current Report
8-K
View
2019
08-15
Current Report
8-K
View
2019
08-02
Current Report
8-K
View
2019
07-24
Current Report
8-K
View
2019
07-17
Current Report
8-K
View
2019
06-19
Current Report
8-K
View
2019
05-14
Current Report
8-K
View
2019
04-30
Current Report
8-K
View
2019
04-26
Current Report
8-K
View
2019
04-15
Current Report
8-K
View
2019
03-27
Current Report
8-K
View
2019
02-26
Current Report
8-K
View
2018
12-27
Current Report
8-K
View
2018
03-23
Current Report
8-K
View
2018
09-07
Current Report
8-K
View
2018
08-07
Current Report
8-K
View
2018
06-15
Current Report
8-K
View
Statement of Changes in Beneficial Ownership
(19)
No records
2024
02-22
Statement of Changes in Beneficial Ownership
Form 4
View
2024
02-07
Statement of Changes in Beneficial Ownership
Form 4
View
2023
12-26
Statement of Changes in Beneficial Ownership
Form 4
View
2023
09-27
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-28
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-21
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2023
08-14
Statement of Changes in Beneficial Ownership
Form 4
View
2022
07-01
Statement of Changes in Beneficial Ownership
Form 4
View
2022
06-27
Statement of Changes in Beneficial Ownership
Form 4
View
Other Preliminary Proxy Statement
(1)
No records
2023
11-17
Other Preliminary Proxy Statement
PRE 14A
View
Quarterly Report
(18)
No records
2023
11-08
Quarterly Report
10-Q
View
2023
08-09
Quarterly Report
10-Q
View
2023
05-04
Quarterly Report
10-Q
View
2022
11-09
Quarterly Report
10-Q
View
2022
08-03
Quarterly Report
10-Q
View
2022
04-27
Quarterly Report
10-Q
View
2021
11-12
Quarterly Report
10-Q
View
2021
08-11
Quarterly Report
10-Q
View
2021
05-06
Quarterly Report
10-Q
View
2020
11-05
Quarterly Report
10-Q
View
2020
08-10
Quarterly Report
10-Q
View
2020
05-05
Quarterly Report
10-Q
View
2019
11-07
Quarterly Report
10-Q
View
2019
08-13
Quarterly Report
10-Q
View
2019
05-13
Quarterly Report
10-Q
View
2018
11-08
Quarterly Report
10-Q
View
2018
08-07
Quarterly Report
10-Q
View
2018
05-03
Quarterly Report
10-Q
View
Prospectus
(20)
No records
2023
07-18
Prospectus
424B5
View
2022
11-09
Prospectus
424B3
View
2022
11-09
Prospectus
424B3
View
2022
11-09
Prospectus
424B3
View
2022
08-03
Prospectus
424B3
View
2022
08-03
Prospectus
424B3
View
2022
08-03
Prospectus
424B3
View
2022
06-27
Prospectus
424B3
View
2022
05-27
Prospectus
424B5
View
2022
04-27
Prospectus
424B3
View
2022
04-27
Prospectus
424B3
View
2022
02-11
Prospectus
424B3
View
2021
11-12
Prospectus
424B3
View
2021
05-06
Prospectus
424B3
View
2021
02-11
Prospectus
424B5
View
2020
11-05
Prospectus
424B3
View
2018
11-08
Prospectus
424B3
View
2018
08-07
Prospectus
424B3
View
2018
05-03
Prospectus
424B3
View
2018
04-03
Prospectus
424B1
View
Other Definitive Proxy Statement
(4)
No records
2023
06-12
Other Definitive Proxy Statement
DEF 14A
View
2022
06-13
Other Definitive Proxy Statement
DEF 14A
View
2021
06-21
Other Definitive Proxy Statement
DEF 14A
View
2020
07-07
Other Definitive Proxy Statement
DEF 14A
View
Initial Ownership Report
(1)
No records
2022
09-06
Initial Ownership Report
Form 3
View
Registration Statement
(5)
No records
2022
06-14
Registration Statement
S-1
View
2022
03-09
Registration Statement
POA No. 1 to Form S-1
View
2022
03-09
Registration Statement
POA No. 2 to Form S-1
View
2022
02-04
Registration Statement
S-1
View
2021
03-23
Registration Statement
S-1
View
Other Preliminary Proxy Statements
(1)
No records
2022
05-27
Other Preliminary Proxy Statements
PRE 14A
View
Prospectus Supplement
(1)
No records
2021
08-11
Prospectus Supplement
424B3
View
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
(2)
No records
2020
07-07
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEFA 14
View
2018
04-27
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEFA14A
View
Other Definitive Proxy Statements
(1)
No records
2019
03-14
Other Definitive Proxy Statements
DEF 14A
View
Other Definitive Proxy Statements
(1)
No records
2019
03-01
Other Definitive Proxy Statements
DEF 14A
View
Preliminary Proxy Soliciting Materials
(1)
No records
2019
02-27
Preliminary Proxy Soliciting Materials
PRER14A
View
8-K
(1)
No records
2019
02-19
8-K
Current Report
View
Other Preliminary Proxy Statements
(1)
No records
2019
02-19
Other Preliminary Proxy Statements
PRE14A
View
Current Report
(1)
No records
2019
01-22
Current Report
8-K
View
Post-Effective amendments for registration status
(1)
No records
2018
03-23
Post-Effective amendments for registration status
POS AM
View
Other definitive proxy statements
(1)
No records
2018
04-27
Other definitive proxy statements
def 14a
View
Notice of Effectiveness
(1)
No records
2018
04-03
Notice of Effectiveness
EFFECT
View
General Statement of Acquisition of Beneficial Ownership
(1)
No records
2018
03-29
General Statement of Acquisition of Beneficial Ownership
SC 13D/A
View
(1)
No records
View
About GeoVax
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Our Technology
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Product Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Investors
Corporate Profile
News
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
SUBMIT
Name
Search
About Us
Company
Leadership
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Clinical Trials
Investors
Corporate Profile
Press Releases
Media
Events & Presentations
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Careers
Contact